7.80
0.26 (3.45%)
0.26 (3.45%)
Upgrade to Real-Time
Afterhours (Closed)
Low
0.2501
High
18.77
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Ocugen Inc | OCGN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.26 | 3.45% | 7.80 | 19:58:36 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 7.60 | 7.52 | 7.94 | 7.93 | 7.54 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 7.81 | 7.86 | 0.05 | 1 | 1 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 47,884 | 14,993,604 | $ 7.78 | $ 116,591,718 | - | 0.2501 - 18.77 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:58:36 | formt | 697 | $ 7.80 | USD |
Period:
Draw Mode:
Ocugen Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 1.55B | 198.76M | 193.50M | $ 42.62k | $ - | -0.31 | -34.20 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | -235.52k | 1.20% |
Ocugen News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical OCGN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 7.44 | 8.75 | 7.14 | 7.98 | 25,151,100 | 0.36 | 4.84% |
| 1 Month | 6.91 | 8.75 | 6.8803 | 7.76 | 11,564,872 | 0.89 | 12.88% |
| 3 Months | 8.20 | 9.35 | 6.11 | 7.59 | 15,922,050 | -0.40 | -4.88% |
| 6 Months | 8.85 | 16.20 | 5.2375 | 9.36 | 42,375,615 | -1.05 | -11.86% |
| 1 Year | 0.3333 | 18.77 | 0.2501 | 7.27 | 45,281,438 | 7.47 | 2,240.23% |
| 3 Years | 3.24 | 18.77 | 0.17 | 5.81 | 29,172,645 | 4.56 | 140.74% |
| 5 Years | 3.24 | 18.77 | 0.17 | 5.81 | 29,172,645 | 4.56 | 140.74% |
Ocugen Description
| Ocugen Inc is a clinical-stage biopharmaceutical company. It is focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases. Ocugen offers a diversified ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules and targets a broad range of high-need retinal and ocular surface diseases. Its product candidate includes OCU200 and OCU300 to treat diabetic macular edema (DME), diabetic retinopathy (DR) and wet age-related macular degeneration (AMD). |
